Acorda Therapeutics
ACOR
#10104
Rank
NZ$1.4 M
Marketcap
$1.13
Share price
0.00%
Change (1 day)
-95.47%
Change (1 year)

EPS for Acorda Therapeutics (ACOR)

EPS in 2023 (TTM): -$17.60

According to Acorda Therapeutics 's latest financial reports the company's current EPS (TTM) is -$16.75. In 2022 the company made an earnings per share (EPS) of -$151.14 an increase over its 2021 EPS that were of -$342.03.

EPS history for Acorda Therapeutics from 2006 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$17.60-88.36%
2022-$151.14-55.81%
2021-$342.03-16.13%
2020-$407.84-65.51%
2019-$1,182-898.61%
2018$148.05-114.88%
2017-$995.26536.84%
2016-$156.28-392.31%
2015$53.46-39.53%
2014$88.424.88%
2013$84.31-89.54%
2012$806.08409.09%
2011$158.34-333.33%
2010-$67.86-85.14%
2009-$456.501.37%
2008-$450.3351.03%
2007-$298.17-68.27%
2006-$939.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.58-121.38%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.33-107.96%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.35-91.92%๐Ÿ‡ฉ๐Ÿ‡ช Germany
-$13.42-19.92%๐Ÿ‡บ๐Ÿ‡ธ USA